Mutual Fund Details
NAV
₹9.5300
as on 11 Oct 2019, 10:30 PM
₹0.0800(0.85%)
Last Change
Schemes Managed By
Start SIP in this Mutual Fund
Min SIP Amount
₹100
Suggested Date
1st of Every Month
Invest via SIP
Investment Performance
would have given a return of
₹103,499
₹106,749
₹93,035
₹94,450
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
₹5,550
Profit (absolute return)
5.55%
in the last
1m
3m
1y
max
+1% Higher Returns
With Direct Plans on Paytm MoneyInvestment Returns
In the last 3 months
2.85%
In the last 6 months
8.01%
In the last 1 year
5.55%
In the last 3 years
NA
In the last 5 years
NA
In the last 10 years
NA
Absolute Returns
CAGR
Scheme Riskometer
low
moderately low
moderate
moderately high
high
Investors understand that their principal will be at high risk
Scheme Information
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend
as of 11 Oct 2019, 10:30 PM
₹1,280.36 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 15 days.
0.81%
Expense Ratio
Plan
Dividend
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 15 days.
Scheme Document
Sectors Holding in this Mutual Fund
as on 30 Sep 2019
Healthcare
87.69%
₹1,122.71 Cr
Financial
4.90%
₹62.76 Cr
Chemicals
1.93%
₹24.75 Cr
Companies Holding in this Mutual Fund
as on 30 Sep 2019
Cipla Ltd.
9.63%
₹123.30 Cr
Sun Pharmaceutical Inds. Ltd.
9.13%
₹116.90 Cr
Lupin Ltd.
6.50%
₹83.22 Cr
Cadila Healthcare Ltd.
6.19%
₹79.25 Cr
Dr. Reddy's Laboratories Ltd.
5.91%
₹75.67 Cr
Biocon Ltd.
5.18%
₹66.32 Cr
Sanofi India Ltd.
4.81%
₹61.59 Cr
SBI Life Insurance Company Ltd.
4.63%
₹59.28 Cr
Laurus Labs Ltd.
4.40%
₹56.34 Cr
Others
4.31%
₹55.18 Cr
View All
View All
Companies Holding in this Mutual Fund
as on 30 Sep 2019
Cipla Ltd.
9.63%
₹123.30 Cr
Sun Pharmaceutical Inds. Ltd.
9.13%
₹116.90 Cr
Lupin Ltd.
6.50%
₹83.22 Cr
Cadila Healthcare Ltd.
6.19%
₹79.25 Cr
Dr. Reddy's Laboratories Ltd.
5.91%
₹75.67 Cr
Biocon Ltd.
5.18%
₹66.32 Cr
Sanofi India Ltd.
4.81%
₹61.59 Cr
SBI Life Insurance Company Ltd.
4.63%
₹59.28 Cr
Laurus Labs Ltd.
4.40%
₹56.34 Cr
Others
4.31%
₹55.18 Cr
View All
View All
This fund's returns:
5.55%Return Duration
1 Year
Tata India Pharma & HealthCare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
-9.55%
-0.23%
1Y Returns
-0.23
Mirae Asset Healthcare Fund Direct - Growth
EquityPharma
Min. Investment
₹1000
Category Returns
-9.55%
-0.23%
1Y Returns
-1.47
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Growth
EquityPharma
Min. Investment
₹100
Category Returns
-9.55%
-0.23%
1Y Returns
-5.55
Nippon India Pharma Fund Direct-Growth
EquityPharma
Min. Investment
₹100
Category Returns
-9.55%
-0.23%
1Y Returns
-7.57
UTI Healthcare Fund Direct-Growth
EquityPharma
Min. Investment
₹500
Category Returns
-9.55%
-0.23%
1Y Returns
-9.30
About ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend is a Equity mutual fund scheme from ICICI Prudential Mutual Fund. This scheme was launched on 13 Jul 2018 and is currently managed by its fund manager Ihab Dalwai. It has an AUM of ₹1,280.36 Crores and the latest NAV decalared is ₹9.530 as on 11 Oct 2019 at 10:30 pm.
ICICI Prudential Pharma Healthcare And Diagnostics (P.H.D) Fund Direct - Dividend scheme return performance in last 1 year is -5.55%, is -3.74% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.
Scheme Details
| AUM: | ₹1,280.36 Cr |
| Category: | Equity: Sectoral-Pharma |
| Launch Date: | 13 Jul 2018 |
| Fund Type: | Open-End |
Scheme Objective
The scheme seeks to generate long-term capital appreciation by creating a portfolio that is invested in equity and equity related securities of pharma, healthcare, hospitals, diagnostics, wellness and allied companies.
AMC Information
ICICI Prudential Mutual Fund
View AMC Details
₹343,463.35 Cr
AUM
232
Schemes
Address
One BKC , A Wing ,13th Floor, Bandra Kurla Complex,400051
Phone Number
Phone : 022-26525000 / 1800-222-999 / 1800-200-6666
Fax : 022-26528100
Email / Website
